Home › NDC Lookup › RxCUI directory › RxCUI 197730

Furosemide 10 MG/ML Oral Solution — RxCUI 197730

Name: Furosemide 10 MG/ML Oral Solution (RxCUI 197730)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 197730 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197730

Official nameFurosemide 10 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asfurosemide 1 % Oral Solution; furosemide 10 MG in 1 mL Oral Solution; furosemide 10 MG per 1 ML Oral Solution; furosemide 40 MG per 4 ML Oral Solution

FDA products mapped10

Package NDCs mapped14

Reported Medicaid activity (SDUD)399,499 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Furosemide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Injectable furosemide is used when you need faster action than a pill can provide, or when you can't take oral medication — for example, in an emergency like acute pulmonary edema...
Why am I getting this as an injection instead of a pill?
The biggest things to watch for are signs of dehydration — feeling very dizzy, lightheaded, or faint, especially when you stand up — and muscle cramps or weakness, which can signal...
What should I watch out for while using furosemide injection?

📖 Read our full Furosemide Injection guide →

🕸️ Concept Web — How Furosemide 10 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Furosemide 10 MG/ML Oral Solution RxCUI 197730 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Furosemide 4603 IN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Furosemide Oral Solution 372280 SCDF
- Furosemide Oral Liquid Product 1162713 SCDG
- Furosemide Oral Product 1162714 SCDG
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- Oral Product 1151131 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Furosemide 10 MG/ML 317376 SCDC

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Furosemide 10 MG/ML SCDC · 317376
Furosemide Oral Solution SCDF · 372280
Furosemide Oral Liquid Product SCDG · 1162713
Furosemide Oral Product SCDG · 1162714

📦 FDA Products & Package NDCs

10 products · 14 package NDCs

14 package NDCs map to RxCUI 197730 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00054-3294-46	60 mL in 1 BOTTLE (0054-3294-46)	Furosemide	Hikma Pharmaceuticals USA Inc.	1988-07-12
00054-3294-50	120 mL in 1 BOTTLE (0054-3294-50)	Furosemide	Hikma Pharmaceuticals USA Inc.	1988-07-12
00054-3298-63	500 mL in 1 BOTTLE, PLASTIC (0054-3298-63)	Furosemide	Hikma Pharmaceuticals USA Inc.	1987-04-22
00054-4297-25	100 TABLET in 1 BOTTLE, PLASTIC (0054-4297-25)	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-4297-31	1000 TABLET in 1 BOTTLE, PLASTIC (0054-4297-31)	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-4299-25	100 TABLET in 1 BOTTLE (0054-4299-25)	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-4299-31	1000 TABLET in 1 BOTTLE (0054-4299-31)	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-4301-25	100 TABLET in 1 BOTTLE, PLASTIC (0054-4301-25)	Furosemide	Hikma Pharmaceuticals USA Inc.	1991-03-13
00054-4301-29	500 TABLET in 1 BOTTLE, PLASTIC (0054-4301-29)	Furosemide	Hikma Pharmaceuticals USA Inc.	1991-03-13
00054-8297-25	10 BLISTER PACK in 1 CARTON (0054-8297-25) / 10 TABLET in 1...	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-8299-25	10 BLISTER PACK in 1 CARTON (0054-8299-25) / 10 TABLET in 1...	Furosemide	Hikma Pharmaceuticals USA Inc.	1983-11-10
00054-8301-25	10 BLISTER PACK in 1 CARTON (0054-8301-25) / 10 TABLET in 1...	Furosemide	Hikma Pharmaceuticals USA Inc.	1991-03-13
17856-3294-01	120 SYRINGE in 1 CASE (17856-3294-1) / 3 mL in 1 SYRINGE	Furosemide	Atlantic Biologicals Corp.	2026-06-23
68094-0756-62	3 TRAY in 1 CASE (68094-756-62) / 10 CUP, UNIT-DOSE in 1 TR...	Furosemide	Precision Dose Inc.	2012-10-23

Observed labelers: Hikma Pharmaceuticals USA Inc. (12) · Atlantic Biologicals Corp. (1) · Precision Dose Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.